BRPI0912749A2 - processo de óleo de krill. - Google Patents

processo de óleo de krill.

Info

Publication number
BRPI0912749A2
BRPI0912749A2 BRPI0912749A BRPI0912749A BRPI0912749A2 BR PI0912749 A2 BRPI0912749 A2 BR PI0912749A2 BR PI0912749 A BRPI0912749 A BR PI0912749A BR PI0912749 A BRPI0912749 A BR PI0912749A BR PI0912749 A2 BRPI0912749 A2 BR PI0912749A2
Authority
BR
Brazil
Prior art keywords
krill oil
oil process
krill
oil
Prior art date
Application number
BRPI0912749A
Other languages
English (en)
Inventor
Breivik Harald
Thorstad Olav
Original Assignee
Pronova Biopharma Norge As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pronova Biopharma Norge As filed Critical Pronova Biopharma Norge As
Publication of BRPI0912749A2 publication Critical patent/BRPI0912749A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C11B1/104—Production of fats or fatty oils from raw materials by extracting using super critical gases or vapours
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/02—Pretreatment
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/12—Refining fats or fatty oils by distillation
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
    • C11B7/0083—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils with addition of auxiliary substances, e.g. cristallisation promotors, filter aids, melting point depressors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
BRPI0912749A 2008-05-15 2009-05-15 processo de óleo de krill. BRPI0912749A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5345508P 2008-05-15 2008-05-15
PCT/NO2009/000184 WO2009139641A1 (en) 2008-05-15 2009-05-15 Krill oil process

Publications (1)

Publication Number Publication Date
BRPI0912749A2 true BRPI0912749A2 (pt) 2017-05-23

Family

ID=41318881

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912749A BRPI0912749A2 (pt) 2008-05-15 2009-05-15 processo de óleo de krill.

Country Status (9)

Country Link
US (1) US8829215B2 (pt)
EP (1) EP2291499B1 (pt)
JP (1) JP2011522913A (pt)
KR (1) KR20110021886A (pt)
CN (1) CN102099451B (pt)
BR (1) BRPI0912749A2 (pt)
CA (1) CA2724463C (pt)
MX (1) MX2010012482A (pt)
WO (1) WO2009139641A1 (pt)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
EP2144618B2 (en) 2007-03-28 2024-11-20 Aker Biomarine Antarctic As Bioeffective krill oil compositions
EP4137128A1 (en) 2008-09-02 2023-02-22 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and a statin, and methods of using same
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MX350088B (es) 2009-04-29 2017-08-25 Amarin Pharma Inc Composicion farmaceutica estable y metodos de uso de la misma.
CN108096209A (zh) 2009-06-15 2018-06-01 阿马里纳制药公司 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法
US20110071176A1 (en) 2009-09-23 2011-03-24 Amarin Pharma, Inc. Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
AU2009354456B2 (en) 2009-10-30 2014-05-08 Tharos Ltd Solvent-free process for obtaining phospholipids and neutral enriched krill oils
US20120207912A1 (en) * 2010-08-11 2012-08-16 E.I. Du Pont De Nemours And Company Aquaculture meat products
EP2603094A1 (en) * 2010-08-11 2013-06-19 E.I. Du Pont De Nemours And Company A sustainable aquaculture feeding strategy
NZ712068A (en) 2010-11-29 2017-03-31 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2012079219A1 (zh) * 2010-12-14 2012-06-21 大连工业大学 由南极磷虾制备虾油脂和制备虾浓缩物或虾粉的方法
CN102071101B (zh) * 2011-01-21 2012-10-10 山东科芮尔生物制品有限公司 一种从南极磷虾中提取富含磷脂的磷虾油的方法
WO2012103685A1 (en) * 2011-02-01 2012-08-09 Nippon Suisan Kaisha, Ltd. Sexual function improving agent
CN102311868B (zh) * 2011-04-29 2017-05-24 塞拉斯有限责任公司 一种无溶剂提取富含磷脂和中性油脂的磷虾油的方法
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
CN102492538B (zh) * 2011-11-14 2013-05-08 辽宁省大连海洋渔业集团公司 一种从南极磷虾中提取高磷脂含量磷虾油的方法
CN102492537B (zh) * 2011-11-14 2013-05-08 辽宁省大连海洋渔业集团公司 南极磷虾提取磷虾油的方法
CN107050457A (zh) 2012-01-06 2017-08-18 翁特拉制药公司 游离酸形式的ω‑3多不饱和脂肪酸的富含dpa组合物
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
EP2846779A4 (en) 2012-05-07 2015-12-16 Omthera Pharmaceuticals Inc STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS
CA3225865A1 (en) 2012-05-14 2013-11-21 Nissui Corporation Method for producing highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants
CA3067012C (en) 2012-06-29 2021-10-05 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
EP2874500A2 (en) * 2012-07-17 2015-05-27 Aker Biomarine Antarctic AS Concentration of omega-3 polyunsaturated fatty acids in krill oil
CN102776063A (zh) * 2012-07-30 2012-11-14 淮阴工学院 一种从克氏原鳌虾废弃物中提取天然虾油的方法
WO2014057362A2 (en) 2012-09-24 2014-04-17 Aker Biopharma As Omega -3 compositions
WO2014060847A1 (en) 2012-09-24 2014-04-24 Aker Biopharma As Use of long chain polyunsaturated fatty acid derivatives to treat sickle cell disease
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271907A1 (en) * 2013-03-14 2014-09-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and krill oil and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
AU2014203179C1 (en) * 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
US20150065572A1 (en) * 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
HUE055277T2 (hu) 2013-12-04 2021-11-29 Nippon Suisan Kaisha Ltd Dihomo-gamma-linolénsavat tartalmazó mikrobális olaj és dihomo-gamma-linolénsavat tartalmazó mikrobális biomassza
CN104694244B (zh) * 2013-12-06 2017-12-08 青岛康境海洋生物科技有限公司 一种双溶剂提取高酯化虾青素高磷脂的磷虾油制备方法
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
EP3232798A1 (en) 2014-12-19 2017-10-25 Aker Biomarine Antarctic AS Enhanced omega-3 formulations
PT3256003T (pt) 2015-02-11 2023-02-15 Aker Biomarine Antarctic As Processo de extração de lipídios
CN114304375A (zh) * 2015-02-11 2022-04-12 阿克海洋生物南极股份公司 脂质组合物
CN107666904B (zh) * 2015-03-26 2022-02-01 提贝托·布鲁泽塞 多不饱和脂肪酸的纯化组合物、其制备方法及其用途
CN105199829A (zh) * 2015-09-06 2015-12-30 江苏江大源生态生物科技股份有限公司 一种超临界co2萃取磷虾油的方法
HK1258568A1 (zh) * 2015-10-05 2019-11-15 Dsm Ip Assets B.V. 油组合物和制备方法
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
CN107418721A (zh) * 2017-04-28 2017-12-01 大连医诺生物股份有限公司 低砷南极磷虾油组合物及其制备方法
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
EP3586641A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
EP3586640A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
EP3586643A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
EP3586642A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Ala enriched polyunsaturated fatty acid compositions
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
KR101966081B1 (ko) 2018-12-05 2019-04-05 이상수 크릴 오일 조성물 및 그의 제조방법
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
US11986452B2 (en) 2021-04-21 2024-05-21 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5476858A (en) 1977-11-28 1979-06-19 Tokai Suisan Kikai Kk Production of protein concentrate of *okiami*
CA1098900A (en) 1977-12-14 1981-04-07 Sergei V. Rogozhin Method for the processing of krill to produce protein, lipids and chitin
US4377526A (en) 1981-05-15 1983-03-22 Nippon Suisan Kaisha, Ltd. Method of purifying eicosapentaenoic acid and its esters
JPS588037A (ja) 1981-07-03 1983-01-18 Nippon Suisan Kaisha Ltd エイコサペンタエン酸またはそのエステルの製法
JPS63162793A (ja) 1986-12-26 1988-07-06 焼津水産化学工業株式会社 脂質の抽出方法
JPH0681583B2 (ja) 1988-06-03 1994-10-19 理研ビタミン株式会社 甲殻類養殖用初期配合飼料
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
JP2909508B2 (ja) 1989-02-14 1999-06-23 マルハ株式会社 オキアミリン脂質の分取方法
JP3040136B2 (ja) * 1990-06-04 2000-05-08 日本水産株式会社 エイコサペンタエン酸またはそのエステルの製造方法
JP3081692B2 (ja) * 1991-11-28 2000-08-28 クロリンエンジニアズ株式会社 オキアミからの色素の抽出分離方法
RU2034492C1 (ru) 1991-12-25 1995-05-10 Борис Николаевич Троицкий Искусственный корм "радуга" для аквариумных рыб
RU2000066C1 (ru) 1992-06-23 1993-09-07 Фирма "Карт" Способ переработки мелких ракообразных с получением хитозана
JP3614177B2 (ja) * 1992-07-21 2005-01-26 日本水産株式会社 高純度ドコサヘキサエン酸またはそのエステルの 製造方法
JPH06248289A (ja) 1993-02-27 1994-09-06 Nippon Suisan Kaisha Ltd 高度不飽和脂肪酸類を選択的に分離回収する方法
JPH08218091A (ja) * 1995-02-17 1996-08-27 Maruha Corp 高純度の高度不飽和脂肪酸およびその誘導体の製造方法
CA2251265A1 (en) 1998-10-21 2000-04-21 Universite De Sherbrooke Process for lipid extraction of aquatic animal tissues producing a dehydrated residue
EP1406641B1 (en) * 2001-06-18 2009-01-07 Neptune Technologies & Bioressources Inc. Krill extracts for prevention and/or treatment of cardiovascular diseases
EP1417211B1 (en) * 2001-07-27 2007-05-30 Neptune Technologies & Bioressources Inc. Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses
JP4410675B2 (ja) * 2002-04-30 2010-02-03 サントリーホールディングス株式会社 アスタキサンチン中鎖脂肪酸エステル、その製造法、およびそれらを含有する組成物
SE0202188D0 (sv) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
JP4310387B2 (ja) * 2002-11-22 2009-08-05 株式会社マルハニチロ水産 ω−３系高度不飽和脂肪酸含有部分グリセリド組成物及びその製造方法
WO2004047554A1 (en) 2002-11-26 2004-06-10 Phares Pharmaceutical Research N.V. Marine lipid compositions
JP2005245379A (ja) * 2004-03-08 2005-09-15 Nippon Suisan Kaisha Ltd 甲殻類の眼球の集合物、使用方法、含有する食品および製造方法
JP2005318878A (ja) * 2004-05-07 2005-11-17 Hideyo Sasaya 健康食品
RU2266949C1 (ru) 2004-05-18 2005-12-27 ФГУП Всероссийский научно-исследовательский институт рыбного хозяйства и океанографии (ВНИРО) Способ получения жира из отходов разделки кальмара
JP2006115750A (ja) 2004-10-21 2006-05-11 Marubeni Nisshin Feed Co Ltd 鰻用飼料及び鰻の飼育方法
GB0506788D0 (en) 2005-04-04 2005-05-11 Biosea Man As Process
AR059659A1 (es) 2006-01-13 2008-04-23 Alfa Copenhagen S S Metodo para la extraccion
NZ547429A (en) 2006-05-24 2009-09-25 Ind Res Ltd Extraction of highly unsaturated lipids with liquid dimethyl ether
WO2008050219A2 (en) 2006-10-24 2008-05-02 Krill A/S Method and equipment' for improved extraction of lipid fractions from aquatic animals and from marine origin
JP2010510208A (ja) 2006-11-16 2010-04-02 プロノヴァ バイオファーマ ノルゲ アーエス オキアミ油およびミールの製造方法
JP5476858B2 (ja) 2009-08-24 2014-04-23 株式会社リコー 測距センサ

Also Published As

Publication number Publication date
JP2011522913A (ja) 2011-08-04
CA2724463A1 (en) 2009-11-19
US20110130458A1 (en) 2011-06-02
EP2291499B1 (en) 2020-02-12
EP2291499A1 (en) 2011-03-09
CA2724463C (en) 2017-10-03
CN102099451B (zh) 2015-07-15
CN102099451A (zh) 2011-06-15
KR20110021886A (ko) 2011-03-04
US8829215B2 (en) 2014-09-09
WO2009139641A1 (en) 2009-11-19
EP2291499A4 (en) 2017-05-24
MX2010012482A (es) 2010-12-01

Similar Documents

Publication Publication Date Title
BRPI0920779A2 (pt) método de produção de óleo biológico.
BRPI0821944A2 (pt) Processo
BRPI0919868A2 (pt) processo
BRPI1015103A2 (pt) processo de fabricação de calçados com sulcos.
BRPI0921374A2 (pt) processo
BRPI0911767A2 (pt) Processo, e, composto.
EP2291499A4 (en) Krill oil process
BRPI0906249A2 (pt) Processo de elaboração de 1,1,1,4,4,4-hexafluoro-2-buteno
BRPI0819625A2 (pt) Processos de produção de lubrificante.
BRPI0909334A2 (pt) processo de produção de álcool microbiano.
BRPI0906607A2 (pt) Agentes de coalescência eficazes.
PT2165971T (pt) Processo de hidrotratamento
BRPI0908725A2 (pt) Processo enzimático
BRPI0816159A2 (pt) Processo para recuperação otimizada de óleo
BRPI0919747A2 (pt) composição de óleo lubrificante.
BRPI0922208A2 (pt) método de mineração de minerio.
BRPI0718075A2 (pt) Processo de hidrogenação
BRPI0822577A2 (pt) Processo de aprimoramento de carvão
BRPI0811869A2 (pt) Processo de formação de emulsão
BRPI0914221A2 (pt) processo, e, composto
BRPI0811543A2 (pt) Processo de geração de cumeno.
IT1396406B1 (it) Stantuffo.
BRPI1012134A2 (pt) processo de carbolinação
BRPI0806679A2 (pt) Processo aperfeiçoado de produção de alquilaromático
BRPI1010553A2 (pt) processo de carbonilação.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C11B 1/10 (2006.01), A23D 9/013 (2006.01), A23D 9/

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2455 DE 23/01/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2670 DE 08-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.